Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxepin vs Nortriptyline in IBS-D
NCT01268709Phase 2Completed
- Sponsor
- Qom University of Medical Sciences
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in Irritable bowel syndrome with diarrhea (IBS-D) comparing Doxepin, Nortriptyline and Placebo (3 arms). Primary endpoints: Abdominal pain at 2 months, Mucus in the stool at 2 months and 2 more. Status: completed.
02
Drugs
doxepinnortriptyline
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01268709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01268709.